Acrivon Therapeutics, Inc. Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Acrivon Therapeutics, Inc. is a biotechnology company focused on precision oncology therapeutics. It is enabled by a differentiated proteomics-based patient selection platform that is broadly applicable across drug classes and modalities. The company concentrates on oncology targets that are challenging to drug and are implicated across many cancers, including those without simple single-gene driver mutations or synthetic lethal contexts. Leveraging its platform, Acrivon aims to rapidly progress in-licensed clinical-stage assets and internally developed programs through accelerated registration trials. The company is headquartered in the greater Boston area, with its address at 700 North Main Street, Cambridge, Massachusetts 02139, United States, and biomarker discovery efforts led by a wholly-owned subsidiary in Lund, Sweden. It employs between 51 and 200 people.

Sign up for free to view info

Company overview Employee directory